Barbara Weber
2022
In 2022, Barbara Weber earned a total compensation of $4.7M as President, Chief Executive Officer and Director at Tango Therapeutics, a 59% decrease compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $363,688 |
---|---|
Option Awards | $3,740,625 |
Salary | $575,000 |
Other | $2,474 |
Total | $4,681,787 |
Weber received $3.7M in option awards, accounting for 80% of the total pay in 2022.
Weber also received $363.7K in non-equity incentive plan, $575K in salary and $2.5K in other compensation.
Rankings
In 2022, Barbara Weber's compensation ranked 697th out of 5,760 executives tracked by ExecPay. In other words, Weber earned more than 87.9% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 697 out of 5,760 | 88th |
Division Manufacturing | 307 out of 3,136 | 90th |
Major group Chemicals And Allied Products | 94 out of 1,422 | 93rd |
Industry group Drugs | 81 out of 1,323 | 94th |
Industry Pharmaceutical Preparations | 60 out of 969 | 94th |
Source: SEC filing on April 24, 2023.
Weber's colleagues
We found two more compensation records of executives who worked with Barbara Weber at Tango Therapeutics in 2022.